Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
American Heart Journal|March 17, 2022
Independence of clinical events committees: A consensus statement from clinical research organizationsErnest Spitzer, Alexander C Fanaroff, C Michael Gibson, et al.
Ophthalmology|July 20, 2020
How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country: Analysis of 478 PatientsYacoub A Yousef, Ibrahim Al-Nawaiseh, Mustafa Mehyar, et al.
Nature Communications|May 27, 2024
Pixel-wise programmability enables dynamic high-SNR cameras for high-speed microscopyJie Zhang, Jonathan Newman, Zeguan Wang, et al.
Trials|April 11, 2020
Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated eventsAlexander C Fanaroff, Ghazala Haque, Betsy Thomas, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Pixel-wise programmability enables dynamic high-SNR cameras for high-speed microscopyJie Zhang, Jonathan Newman, Zeguan Wang, et al.
Heart (British Cardiac Society)|February 9, 2013
Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes?Sabiha Gati, Navin Chandra, Rachel Louise Bennett, et al.
BMJ Open|July 12, 2019
Randomised controlled trial to investigate the effectiveness of thoracic epidural and paravertebral blockade in reducing chronic post-thoracotomy pain (TOPIC): a pilot study to assess feasibility of a large multicentre trialJoyce Yeung, Lee Middleton, Kostas Tryposkiadis, et al.
The Primary Care Companion for CNS Disorders|July 2, 2024
Advances in Ketogenic Diet Therapies in Pediatric Epilepsy: A Systematic ReviewDilshad Parveen, Vidisha Jain, Dhivya Kannan, et al.
Cancer|November 26, 2014
Cognitive function and social attainment in adult survivors of retinoblastoma: a report from the St. Jude Lifetime Cohort StudyTara M Brinkman, Thomas E Merchant, Zhenghong Li, et al.
Bioorganic & Medicinal Chemistry Letters|September 26, 2018
Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin diseaseMichael D Barker, John Liddle, Francis L Atkinson, et al.
Pageof 18